Page 9 - Genmark Diagnostics News Today

BENGALURU (March 15): European stocks ended flat on Monday, with declines led by financial and mining stocks, while gains in betting firm Flutter Entertainment and optimism about a strong economic rebound helped limit losses. The pan-European STOXX 600 index was flat, inching closer to a record peak set last year, with travel and leisure, automakers, and food & beverage sectors, among top gainers.

Home / Top News / GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. NEW YORK and SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnost...

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of GenMark Diagnostics, Inc. (NASDAQ: GNMK) to Roche is fair to GenMark shareholders. Under the terms of the merger agreement, Roche will acquire all outstanding shares of GenMark common stock for $24.05 per share in cash.

Roche Buys Covid Test Maker GenMark for $1.8B Related Stories March 19, 2021 February 26, 2021 January 19, 2021 Roche Holding AG has agreed to buy GenMark Diagnostics Inc. for about $1.8 billion to gain a provider of fast tests for infectious diseases, including Covid-19. The Swiss drugmaker will pay $24.05 a share in cash, it said in a statement. The boards of both companies approved the transaction. GenMark’s tests can detect multiple pathogens from a single patient sample. The pandemic ha...

European stocks ended flat on Monday, with declines led by financial and mining stocks, while gains in betting firm Flutter Entertainment and optimism about a strong economic rebound helped limit losses.

Roche to buy Covid test maker GenMark Diagnostics for $1.8 bn

Under the terms of the merger agreement, Roche will promptly commence a tender offer to acquire all outstanding shares of GenMark’s common stock, and GenMark will file a recommendation statement containing the unanimous recommendation of the GenMark board that GenMark stockholders tender their shares to Roche

/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GenMark Diagnostics,...

- Molecular Partners [MOLN.CH] +5% (trial), AstraZeneca [AZN.UK] -1% (Ireland suspends use of vaccine) - Speakers - BOE Gov Bailey0reiterated stance that current lockdown was having less effect on economy compared to a year ago. Had a more balanced picture on risks and could see a spending of savings and viewed as an upside risk. Very helpful that furlough scheme to extend beyond end of covid restrictions. Would expect a pickup in inflation towards 2% in the coming months; but question was ...

Roche has inked a $1.8 billion, all-cash deal for GenMark Diagnostics, to acquire its molecular tests designed to screen patient samples for multiple infections simultaneously.